B-type Natriuretic Peptide Test Kit (Fluorescent Immunoassay)

B-Type Natriuretic Peptide (BNP) detection kit using fluorescence immunoassay technology for cardiac biomarker measurement. Enables rapid assessment of heart failure and acute dyspnea in clinical and laboratory settings. Supports diagnostic decision-making through quantitative BNP level analysis with high sensitivity and specificity.

Immunoassay for B-type natriuretic peptide measurement in heart failure evaluation. Supports risk stratification and disease monitoring.

A chemiluminescence immunoassay kit for the quantitative determination of B-type natriuretic peptide (BNP) in human serum or plasma. The kit contains reagents for 100 tests and is used in cardiac heart failure assessment and monitoring.

Rapid immunoassay for measuring NT-proBNP levels in serum or plasma samples. Applied for heart failure diagnosis and cardiac dysfunction assessment in clinical settings.

Fluorescence immunoassay kit for rapid dual cardiac biomarker detection. Enables quantitative measurement of cardiac markers to support acute coronary syndrome diagnosis and risk stratification in clinical laboratory and point-of-care settings. Compatible with automated analyzer platforms for efficient high-throughput testing.

Chemiluminescence immunoassay kit for N-terminal pro-B-type natriuretic peptide measurement containing 100 tests. Applied in cardiac dysfunction screening and heart failure diagnosis in healthcare settings.

NT-proBNP is an in vitro diagnostic test for rapid quantification of N-terminal pro-B-type natriuretic peptide, a cardiac biomarker used to diagnose and assess heart failure severity. The test is performed on automated chemiluminescent immunoassay analyzers, enabling quick and accurate results for cardiac risk stratification in clinical settings.

Immunoassay tests for B-type natriuretic peptide and heart failure-related biomarkers. These products support heart failure diagnosis and prognosis assessment.

Cardiac Injury Triple Test Kit using fluorescence immunoassay technology for rapid detection of cardiac biomarkers. Enables simultaneous measurement of multiple cardiac injury markers to support acute coronary syndrome diagnosis and risk stratification in clinical laboratory and point-of-care settings.

Cardiopulmonary function assessment kit utilizing fluorescence immunoassay technology for rapid detection and quantification of cardiac and pulmonary biomarkers. Enables clinical laboratories to evaluate cardiopulmonary status through simultaneous measurement of five key analytes, supporting diagnosis and risk stratification in acute and chronic cardiopulmonary conditions. Designed for integration with automated analyzer platforms to deliver timely results for patient management.

A diagnostic test kit for measuring BNP levels using nano-enzyme fluorescence immunochromatography method. Applied in heart failure diagnosis and monitoring.